Genital condylomata in a patient receiving infliximab for Crohn’s disease
- 10 June 2004
- journal article
- case report
- Published by Oxford University Press (OUP)
- Vol. 80 (944), 358-359
- https://doi.org/10.1136/pgmj.2003.009332
Abstract
Infliximab is a monoclonal antibody against tumour necrosis factor-alpha. Recent studies have shown that it is effective in treating patients with refractory Crohn’s disease and in those with Crohn’s fistulae. Though this drug is found to be safe in clinical trials, sporadic reports of serious complications have been recorded in the literature. The case of a patient who developed profuse genital warts after infliximab treatment is reported. The literature is reviewed and information is presented on side effects and complications as a result of infliximab therapy.Keywords
This publication has 15 references indexed in Scilit:
- Multiple bilateral eyelid molluscum contagiosum lesions associated with TNFα-antibody and methotrexate therapyAmerican Journal of Ophthalmology, 2002
- Infliximab retreatment in adults and children with Crohn's disease: risk factors for the development of delayed severe systemic reactionThe American Journal of Gastroenterology, 2002
- Delayed Hypersensitivity Reaction and Acute Respiratory Distress Syndrome Following Infliximab InfusionInflammatory Bowel Diseases, 2002
- Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's diseaseGut, 2002
- Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritisPublished by Oxford University Press (OUP) ,2002
- Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathwayGastroenterology, 2001
- Infliximab-induced aseptic meningitisThe Lancet, 2001
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Clinical Presentation and Natural Course of Anogenital WartsAmerican Journal Of Medicine, 1997